⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28687853 | 0.75 | — | — | |
| SCHEMBL360281 | 0.75 | — | — | |
| SCHEMBL30383 | 0.75 | — | — | |
| Ammonia Solution, Strong SCHEMBL2540910 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL6676854 | 0.73 | LPAR2 (0.33) | — | |
| Phosphoric Acid SCHEMBL10534010 | 0.73 | KDM4E (0.37) | — | |
| Hydrochloric Acid SCHEMBL11081569 | 0.73 | LPAR2 (0.33) | — | |
| SCHEMBL2538056 | 0.73 | — | — | |
| SCHEMBL2543714 | 0.73 | — | — | |
| SCHEMBL2542186 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7369 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023107896-A9 | TREATMENT OF FGG RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-07-11 | — | — | WO | claimed |
| WO-2024137663-A2 | TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-06-27 | — | — | WO | claimed |
| WO-2024129886-A2 | TREATMENT OF MST1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2024118979-A1 | TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-06-06 | — | — | WO | claimed |
| US-20240175031-A1 | TREATMENT OF MST1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. | 2024-05-30 | — | — | US | claimed |
| EP-4359535-A1 | TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-05-01 | — | — | EP | claimed |
| EP-4355878-A1 | TREATMENT OF MTRES1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-04-24 | — | — | EP | claimed |
| EP-4355355-A1 | TREATMENT OF PLIN1 RELATED DISEASES AND DISORDERS | EMPIRICO INC. (US) | 2024-04-24 | — | — | EP | claimed |
| WO-2024077262-A2 | METHODS AND COMPOSITIONS FOR SILENCING ELAVL2 EXPRESSION FOR THE TREATMENT OF DISEASE | UNIVERSITY OF MASSACHUSETTS (US) | 2024-04-11 | — | — | WO | claimed |
| US-20240093203-A1 | SOLUBLE INTERLEUKIN-7 RECEPTOR (SIL7R) MODULATING THERAPY TO TREAT AUTOIMMUNE DISEASES AND CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2024-03-21 | — | — | US | claimed |
| EP-0652890-A1 | OLIGONUCLEOTIDE ALKYLPHOSPHONOTHIOATES | HYBRIDON, Inc. (US) | 1995-05-17 | — | — | EP | claimed |
| WO-1995009236-A9 | USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY | — | 1995-05-04 | — | — | WO | claimed |
| EP-0649467-A1 | SELF-STABILIZED OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS | HYBRIDON, Inc. (US) | 1995-04-26 | — | — | EP | claimed |
| WO-1995009236-A1 | USING ANTISENSE OLIGONUCLEOTIDES TO MODULATE NERVE GROWTH AND TO REVERSE β/A4 AMYLOID-INDUCED MORPHOLOGY | THE GENERAL HOSPITAL CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| WO-1994023028-A2 | MODIFIED OLIGONUCLEOTIDES HAVING IMPROVED ANTI-INFLUENZA ACTIVITY | HYBRIDON, INC. (US) | 1994-10-13 | — | — | WO | claimed |
| WO-1994017093-A1 | OLIGONUCLEOTIDE ALKYLPHOSPHONATES AND ALKYLPHOSPHONOTHIOATES | HYBRIDON, INC. (US) | 1994-08-04 | — | — | WO | claimed |
| WO-1994015946-A1 | SYNTHESIS OF DIMMER BLOCKS AND THEIR USE IN ASSEMBLING OLIGONUCLEOTIDES | HYBRIDON, INC. (US) | 1994-07-21 | — | — | WO | claimed |
| WO-1994002499-A1 | OLIGONUCLEOTIDE ALKYLPHOSPHONOTHIOATES | HYBRIDON, INC. (US) | 1994-02-03 | — | — | WO | claimed |
| WO-1994001550-A1 | SELF-STABILIZED OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS | HYBRIDON, INC. (US) | 1994-01-20 | — | — | WO | claimed |
| US-4354977-A | STEROID CONJUGATES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1982-10-19 | — | — | US | claimed |